Evidence map›Paper›PMID 20127417›Full record

ArticleJournal of inherited metabolic disease2010

A novel mutation in LMBRD1 causes the cblF defect of vitamin B(12) metabolism in a Turkish patient.

Susann Gailus, Terttu Suormala, Ayse Gül Malerczyk-Aktas, Mohammad R Toliat, Tanja Wittkampf, Martin Stucki, Peter Nürnberg, Brian Fowler, Julia B Hennermann, Frank Rutsch

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of inherited metabolic disease, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Transcellular transport of cobalamin in aortic endothelial cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  8. Article
  9. Article
  10. Review
  11. Methylmalonic Acidemia Diagnosis by Laboratory Methods.Reports of biochemistry & molecular biology · 2016
    Article
  12. Article
  13. Article
  14. LMBRD1: the gene for the cblF defect of vitamin B₁₂ metabolism.Journal of inherited metabolic disease · 2011
    Review
  15. Review
  16. Insights into lysosomal cobalamin trafficking: lessons learned from cblF disease.Journal of molecular medicine (Berlin, Germany) · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Susann GailusDepartment of General Pediatrics, Münster University Children's Hospital, Germany.
Terttu Suormala
Ayse Gül Malerczyk-Aktas
Mohammad R Toliat
Tanja Wittkampf
Martin Stucki
Peter Nürnberg
Brian Fowler
Julia B Hennermann
Frank Rutsch
University Hospital Münster · DEUniversity Children’s Hospital Basel · CHCharité - Universitätsmedizin Berlin · DECologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases · DESwiss Integrative Center for Human Health · CHUniversitätsklinikum Gießen und Marburg · DEUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the cblF defect of vitamin B(12) (cobalamin) metabolism, cobalamin is trapped in lysosomes. Consequently, cobalamin coenzyme synthesis is blocked, and cofactors for methionine synthase and methylmalonyl-coenzyme A (CoA) mutase are deficient. We recently identified LMBRD1 as the causative gene located on chromosome 6q13 and showed that 18 out of 24 alleles in unrelated patients carried the deletion c.1056delG (p.L352fsX18) (Rutsch et al. (Nat Genet 41:234-239, 2009). LMBRD1 encodes the lysosomal membrane protein LMBD1, which presumably facilitates lysosomal cobalamin export. Our patient is the second child of consanguineous Turkish parents. He presented on the second day of life with cerebral seizures due to intraventricular hemorrhage. Plasma homocysteine and urinary methylmalonic acid levels were elevated, and serum cobalamin level was decreased. Synthesis of both cobalamin coenzymes was deficient in cultured skin fibroblasts. The cblF defect was confirmed by somatic complementation analysis. Sequencing of LMBRD1 revealed the novel deletion c.1405delG (p.D469fsX38) on both alleles. Real-time polymerase chain reaction (PCR) revealed reduced messenger RNA (mRNA) levels in patient fibroblasts compared with controls. Transfection of patient fibroblasts with the LMBD1 wild-type complement DNA (cDNA) rescued coenzyme synthesis and function, confirming this new deletion as an additional cause of the cblF defect. This case adds to the spectrum of clinical presentations and mutations of this rare disorder of lysosomal transport.

Indexed as

Mutation5-Methyltetrahydrofolate-Homocysteine S-MethyltransferaseAllelesFemaleFibroblastsHomocysteineHumansLysosomesMaleMethylmalonic AcidMethylmalonyl-CoA MutaseNucleocytoplasmic Transport ProteinsTurkeyVitamin B 125-Methyltetrahydrofolate-Homocysteine S-MethyltransferaseHomocysteineLMBRD1 protein, humanMethylmalonic AcidMethylmalonyl-CoA MutaseNucleocytoplasmic Transport ProteinsVitamin B 12

Identifiers

PMID20127417
OpenAlexW2151697113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.